471 El Camino Real Ste 101
Santa Clara, California 95050-4482
Phone: 14082070700
si-bone.com
SI-BONE to present at Canaccord Genuity Growth Conference. Learn about their sacropelvic disorder treatments and growth strategies. Join the fireside chat on Aug 14, 2024, or access the webcast for key investor insights.
SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ETCompany ParticipantsSaqib Iqbal - Senior Director of Investor…
SANTA CLARA, Calif. (AP) — SANTA CLARA, Calif. (AP) — Si-Bone Inc. (SIBN) on Monday reported a loss of $8.9 million in its second quarter.
SI-Bone (SIBN) has shared an announcement. Daniel Wolf has been elected as a director of the Company by its board, starting from August 5, 2024. He…
SI-BONE reports robust Q2 2024 results: 20% revenue growth, improved net loss, and increased 2024 guidance. Discover key financial highlights and operational achievements driving the company''s positive outlook.
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, August 5, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.